Appeal No. 1999-1417 Application 08/268,730 With the plethora of new information about the NMDA receptor-ionophore complex, one tends to forget that non-NMDA receptors can also mediate excitotoxic events. An instructive case in point is the recent evidence implicating KA receptors in domoate poisoning in which the resultant dementia is manifested most prominently in the elderly. Thus, although we know less about the physiology and makeup of non-NMDA receptors, as new information becomes available, it will probably lead to the recognition of new links between both NMDA and non-NMDA receptor-mediated processes and neuropsychiatric disorders. It is wise, therefore, to keep an open mind regarding the ultimate significance that can be ascribed to excitotoxic processes in human neuropsychiatric diseases, and the promise of anti-excitotoxic strategies for preventing such diseases. [Olney, page 66] We agree that the in vitro and in vivo studies set forth in applicants’ specification are limited in scope and insufficient to teach those skilled in the art how to use the full scope of the claimed invention without undue experimentation. In the Appeal Brief received October 15, 1996, page 20, second complete paragraph, applicants state that The Examiner’s attention is . . . directed to the copy of the Declaration enclosed with the Proposed Amendment of May 4, 1994, which was submitted under 37 C.F.R. § 1.132 together with Attachments 1 and 2 and Enclosures 1 and 2 of said Declaration. It can be seen that applicants invite attention to declaration evidence submitted in parent application 07/443,657 without presenting any argument or arguments, with a reasonable degree of specificity, based on that declaration. In this regard, applicants do not comply with the pertinent regulations governing practice and procedure before the Board of Patent Appeals and Interferences. See 37 CFR § 1.192(a) (1996), requiring that appellant’s brief “set forth the authorities and arguments on which appellant will rely to maintain the appeal.” 10Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 NextLast modified: November 3, 2007